[Long-term results of surgical treatment for renal pelvic and ureteral tumors]. 1995

M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
Department of Urology, Toranomon Hospital.

Fifty eight cases of primary tumors in the renal pelvis and ureter were treated at Toranomon Hospital between 1983 and 1992. They consisted of 32 renal pelvic tumors, 21 ureteral tumors and 5 tumors at both sites. The age of the patients ranged from 30 to 84 years (mean 63.1). Surgery was performed in 56 cases. Radical nephroureterectomy with concomitant ipsilateral retroperitoneal lymph node dissection was performed in 38 cases. The other surgeries were radical nephroureterectomy without lymph node dissection in 9, nephrectomy in 4, resection of ureter and reanastomosis in 3, radical nephroureterectomy and cystectomy in 1 and partial nephrectomy in 1. Pathologically, 53 were transitional cell carcinoma (TCC), 2 were TCC plus squamous cell carcinoma and 1 was TCC plus adenocarcinoma. Over-all survival rates (Kaplan-Meier) of 56 surgical cases at 1, 3, 5 years were 92.2, 83.7 and 72.8%, respectively. Combination chemotherapy (M-VAC or CAP) was performed in 9 cases of metastatic disease and 1 case of bilateral disease. Of these 10 cases, one achieved complete remission, 2 no change and 7 had progressive disease. Adjuvant chemotherapy was performed in 21 cases after surgery. These 21 patients were of high risk in recurrence either Grade 3 or pT3. However, the 5-year survival rate was 77.3% in these patients. Thus we conclude that the adjuvant chemotherapy in high risk patients was effective in our cases.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D007682 Kidney Pelvis The flattened, funnel-shaped expansion connecting the URETER to the KIDNEY CALICES. Renal Pelvis,Pelvis, Kidney,Pelvis, Renal
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females

Related Publications

M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
December 1975, The Journal of urology,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
August 1989, Hinyokika kiyo. Acta urologica Japonica,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
December 1986, The Journal of urology,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
January 1989, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
January 1965, Voprosy onkologii,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
January 1977, Padiatrie und Grenzgebiete,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
November 2010, Injury,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
February 1970, The American surgeon,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
November 1986, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Yokoyama, and M Kano, and M Sakai, and H Oda, and K Inoue, and K Kitahara, and M Kanemura, and M Osada
March 1995, Japanese heart journal,
Copied contents to your clipboard!